Brave Asset Management’s Boston Scientific BSX Stock Holding History

Brave Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$24K	–	179
2016 Q3	$24K	Hold	1,000	–	–	0.02%	272
2016 Q2	$23K	Hold	1,000	–	–	0.02%	277
2016 Q1	$19K	Hold	1,000	–	–	0.01%	296
2015 Q4	$18K	Hold	1,000	–	–	0.01%	302
2015 Q3	$16K	Hold	1,000	–	–	0.01%	302
2015 Q2	$18K	Hold	1,000	–	–	0.01%	314
2015 Q1	$18K	Hold	1,000	–	–	0.01%	318
2014 Q4	$13K	Hold	1,000	–	–	0.01%	340
2014 Q3	$12K	Hold	1,000	–	–	0.01%	337
2014 Q2	$13K	Hold	1,000	–	–	0.01%	338
2014 Q1	$14K	Hold	1,000	–	–	0.01%	325
2013 Q4	$12K	Buy	+1,000	New	+$11.8K	0.01%	331

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Brave Asset Management's BSX Position: Q4 2016 in Review

Brave Asset Management sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 1,000 shares — an estimated $24K sold.

Brave Asset Management first reported a position in BSX in Q4 2013 and held it in 12 quarters. The position peaked at $24K in Q3 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

Brave Asset Management reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 1,000 Boston Scientific shares in Q4 2016, an estimated $24K.
Brave Asset Management first reported a position in Boston Scientific in Q4 2013 and held it in 12 quarters.
Brave Asset Management's Boston Scientific position peaked at $24K in Q3 2016.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.